Internal Medicine · Oakland, CA
NPI
1205922077
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
275 W Macarthur Blvd
Oakland, CA, 94611
Phone (510) 752-1000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.1M
1,186 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Eva S Thomas prescribed most often to Medicare patients was Anastrozole, with 449 prescriptions and refills. In total Eva S Thomas wrote 1,186 Medicare prescriptions that cost $3.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 449 | 1,349 | 155 | $12K |
| Ibrance Palbociclib | 114 | 114 | 15 | $1.8M |
| Tamoxifen Citrate Generic | 105 | 349 | 35 | $2,749 |
| Letrozole Generic | 69 | 151 | 16 | $1,122 |
| Exemestane Generic | 67 | 190 | 26 | $5,231 |
| Alendronate Sodium Generic | 54 | 150 | 17 | $529 |
| Dexamethasone Generic | 42 | 44 | 19 | $683 |
| Ondansetron Hcl Generic | 22 | 22 | 15 | $192 |
| Imatinib Mesylate Generic | 20 | 20 | Under 11 | $978 |
| Everolimus Generic | 20 | 20 | Under 11 | $6,926 |
| Piqray Alpelisib | 16 | 16 | Under 11 | $383K |
| Prochlorperazine Maleate Generic | 16 | 16 | Under 11 | $228 |
| Verzenio Abemaciclib | 14 | 14 | Under 11 | $223K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 13 | 13 | Under 11 | $259 |
| Xarelto Rivaroxaban | 13 | 39 | Under 11 | $18K |
Brand drugs: 203 claims; generic drugs: 983 claims; opioid claims: 19.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Eva S Thomas were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.